STVN 📈 Stevanato Group SpA - Overview

Stevanato Group SpA is a global provider of integrated solutions for the bio-pharma and healthcare industries, operating across multiple continents, including Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company's extensive product portfolio encompasses containment solutions, drug delivery systems, medical devices, and diagnostic solutions, all designed to cater to the complex needs of the pharmaceutical and healthcare sectors.

The company's business is segmented into two primary divisions: Biopharmaceutical and Diagnostic Solutions, and Engineering. The Biopharmaceutical and Diagnostic Solutions segment focuses on developing and manufacturing products such as visual inspection machines, assembling and packaging machines, and glass forming machines, which are critical components in the production of pharmaceuticals and medical devices. On the other hand, the Engineering segment is responsible for designing and producing custom-made machinery and equipment for the pharmaceutical and healthcare industries.

With a history dating back to 1949, Stevanato Group SpA has established itself as a leading player in the healthcare equipment industry, with a strong presence in the global market. As a subsidiary of Stevanato Holding S.R.L, the company is headquartered in Piombino Dese, Italy, and is listed on the New York Stock Exchange (NYSE) under the ticker symbol STVN. The company's common stock is classified under the GICS Sub Industry of Health Care Equipment, with the ISIN code IT0005452658. For more information, investors and stakeholders can visit the company's website at https://www.stevanatogroup.com.